Tokyo, Japan

Kazuko Nakazono

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignees: Fukuoka University, Kinki University, Tokyo Institute of Technology. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuko Nakazono. Retrieved from https://idiyas.com/inventor/kazuko-nakazono-ignarhbi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuko Nakazono: Innovator in Antitumor Agents

Introduction

Kazuko Nakazono is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of antitumor agents. Her innovative work focuses on creating compounds that can effectively target tumor cells.

Latest Patents

Kazuko Nakazono holds a patent for a rotaxane compound that serves as an antitumor agent. This compound is designed to remain within tumor cells for an extended period, making it suitable for topical treatment. The patent specifically discloses a rotaxane compound that contains a base structure represented by a specific chemical formula, where certain parameters are defined to enhance its efficacy.

Career Highlights

Throughout her career, Kazuko Nakazono has worked with notable organizations, including Wan Station Co., Ltd. and the Tokyo Institute of Technology. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Kazuko has collaborated with esteemed colleagues such as Toshikazu Takata and Yasuhito Koyama. These partnerships have enriched her research and fostered innovation in her field.

Conclusion

Kazuko Nakazono's work in developing antitumor agents exemplifies her dedication to advancing medical science. Her innovative contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…